It found that research has shifted from general TRPV1 studies to focus on its structure and roles in diseases like pain, cancer, and neurodegenerative conditions.
Heliyon · 9 authors, 4 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
It found that research has shifted from general TRPV1 studies to focus on its structure and roles in diseases like pain, cancer, and neurodegenerative conditions.
The primary research area was neuroscience, with the United States as the leading publishing country. Analysis of keywords indicates an initial broad study of TRPV1, with recent research focusing on TRPV1 structure and its involvement in diseases. The analysis concludes that TRPV1 disease research centers on pain, cancer, and neurodegenerative diseases, and that both agonists and antagonists are moving toward clinical use.